AFP and hepatocellular carcinoma: After stratifying by the BCLC stage, patients with BCLC-B HCC with medium TBS and low AFP had a similar risk of early recurrence and 5-year all-cause mortality versus individuals with BCLC-0/A HCC (Figure 3); these data suggested that this subset of BCLC-B patients benefited from resection beyond the current BCLC resection criteria [11,28,29,30,31].